1. 411: FOUR-FACTOR PCC VERSUS ANDEXANET ALFA FOR ORAL FACTOR XA INHIBITOR-ASSOCIATED MAJOR BLEEDS. (16th December 2021) Authors: Kafka, Wesley; Nowling, Anthony; Patel, Apexa Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 411: FOUR-FACTOR PCC VERSUS ANDEXANET ALFA FOR ORAL FACTOR XA INHIBITOR-ASSOCIATED MAJOR BLEEDS. (January 2022) Authors: Kafka, Wesley; Nowling, Anthony; Patel, Apexa Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 646: Utility of Rapid Viral Polymerase Chain Reaction in Internal Medicine Patients. (January 2021) Authors: Nowling, Anthony; Czupryn, Michael; Laws, Kiarra Journal: Critical care medicine Issue: Volume 49:Supplement 1 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗